n any of several drugs that control or kill neoplastic cells; used in chemotherapy to kill cancer cells; all have unpleasant side effects that may include nausea and vomiting and hair loss and suppression of bone marrow function
Verastem cancer treatment gets European incentives Cancer drug developer Verastem Inc. said Thursday that its most advanced experimental treatment was awarded orphan drug status in the European Union. The decision by the European Medicines Agency means ...
June 13, 2013 - Associated Press via Yahoo! News
Aveo defends kidney cancer drug rejected by the FDA A day after saying US regulators rejected their kidney cancer drug application and faulted their clinical results as “unintepretable,” Aveo Pharmaceuticals Inc. executives Tuesday defended their program and said they still believe their experimental drug can effectively treat kidney cancer. In a conference call with industry analysts, executives of the Cambridge biotechnology company insisted ...
June 11, 2013 - Boston Globe